Open AccessRiociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Author(s) -
Natalia A. Tsareva,
С. Н. Авдеев
Publication year - 2016
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2016-4-20-27
Subject(s) - pulmonary hypertension , riociguat , medicine , cardiology , endothelial dysfunction , pathological , thrombosis , vasoconstriction , pathophysiology , pulmonary artery , disease , hypoxic pulmonary vasoconstriction , vasodilation , endothelium , intensive care medicine , chronic thromboembolic pulmonary hypertension